Simon Farkas
Overview
Explore the profile of Simon Farkas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel A, Ludwinski F, Kerr A, Farkas S, Kapoor P, Bertolaccini L, et al.
Sci Transl Med
. 2024 Jun;
16(752):eadf0555.
PMID: 38896604
Despite decades of effort aimed at developing clinically effective cell therapies, including mixed population mononuclear cells, to revascularize the ischemic limb, there remains a paucity of patient-based studies that inform...
2.
Farkas S, Simara P, rehakova D, Veverkova L, Koutna I
Front Cell Dev Biol
. 2020 Jun;
8:309.
PMID: 32509776
Human pluripotent stem cells (hPSCs) are a promising source of autologous endothelial progenitor cells (EPCs) that can be used for the treatment of vascular diseases. However, this kind of treatment...
3.
Eiselleova L, Lukjanov V, Farkas S, Svoboda D, Stepka K, Koutna I
Stem Cells Int
. 2019 Mar;
2019:1375807.
PMID: 30863449
The eukaryotic nucleus is a highly complex structure that carries out multiple functions primarily needed for gene expression, and among them, transcription seems to be the most fundamental. Diverse approaches...
4.
Simara P, Tesarova L, rehakova D, Farkas S, Salingova B, Kutalkova K, et al.
Stem Cells Dev
. 2017 Nov;
27(1):10-22.
PMID: 29117787
New approaches in regenerative medicine and vasculogenesis have generated a demand for sufficient numbers of human endothelial cells (ECs). ECs and their progenitors reside on the interior surface of blood...